September 14th, 2015
The malignancy of prostate gland is the product of abnormal mitotic division of lining cells; thereby leading to a wide array of sexual and urinary complications. Although, most cases of advanced prostate malignancy are managed by invasive procedures (such as surgical interventions, radiation therapy, cryotherapy, high intensity ultrasound treatment or brachytherapy); the risk of complications or adverse effects can greatly limit the therapeutic efficacy. Fortunately, due to early screening recommendations and periodic prostate examinations, most cases of prostate cancer are identified in the early stages. In other words, with more sophisticated screening guidelines, the need or requirement of invasive therapies have decreased significantly over the past few years.
There are several non-invasive and natural modalities of care that can slow down or stop the progression of a pre-malignant lesion to invasive prostate cancer. The nature and course of treatments is usually decided after identifying the stage and grade of tumor. For example, early changes in the prostate lining tissue are generally managed via natural remedies (such as supplementation and lifestyle modifications).
According to a new research study reported in peer reviewed Contemporary Clinical Trials (2), the investigators explored the potential effects of different supplements (vitamins and minerals) as well as lifestyle modifications on the course of prostate malignancy. The results revealed that the nutrition and supplement intake can indeed help in slowing down the progression of prostate cancer by improving the natural immune defenses.
Based on the extensive research and analysis, several natural ingredients have been known to influence the overall outcomes. For example, most statistically significant nutrients include; vitamin E and C, soy, fish oil and minerals like selenium.
As discussed previously, the response to therapy and type of natural regimen varies according to the patient factors, overall health of patient and staging of cancer. It is imperative to mention that dosing and dosing combination also plays a vital role. For example, it is believed that toxic intake of vitamin E can lead to prostate cancer in the men. Similarly the use of soy which contains essential amounts of isoflavones is also effective in the management of prostate cancer; but excessive soy can aggravate the risk of other complications.
Based on several studies; following combinations and dosing frequencies are usually recommended for the management of prostate cancer.
Vitamin E |
600-1600 IU |
Vitamin C |
1000-2000 mg |
Fish oil |
200 microgram |
Selenium |
2-8 grams |
Soy |
2-3 servings/week |
Benign prostate cancer is usually less of a problem; however, once the cancer cells begin to metastasize to other organs or parts of body via new vascular formation (also referred to as angiogenesis); active interventions usually becomes inevitable. Various research studies indicates that progression of a benign prostate cancer can be prevented by dietary modification and active supplementation.
Other natural remedies include:
It is imperative to mention that not all the cases of prostate malignancy are ideal candidates for natural treatment. Speak to your primary care provider to discuss possible options and recommended solutions.
1. Grimm, P., Billiet, I., Bostwick, D., Dicker, A. P., Frank, S., Immerzeel, J., … & Langley, S. (2012). Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU international, 109(s1), 22-29.
2. Manson, J. E., Bassuk, S. S., Lee, I. M., Cook, N. R., Albert, M. A., Gordon, D., … & Buring, J. E. (2012). The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemporary clinical trials, 33(1), 159-171.
3. Klein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., … & Baker, L. H. (2011). Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama, 306(14), 1549-1556.
4. Glinskii, O. V., Sud, S., Mossine, V. V., Mawhinney, T. P., Anthony, D. C., Glinsky, G. V., … & Glinsky, V. V. (2012). Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. Neoplasia, 14(1), 65-73.
5. Zu, K., Mucci, L., Rosner, B. A., Clinton, S. K., Loda, M., Stampfer, M. J., & Giovannucci, E. (2014). Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. Journal of the National Cancer Institute, djt430.
Schedule your private consultation with Dr. Elist
Through experience, empathy, and patient empowerment, Dr. Elist offers a comprehensive and detail-oriented treatment plan for every patient. Schedule your consultation to discuss treatments for men in Los Angeles with premier surgeon Dr. James Elist, and begin your journey confident that your best results are just ahead of you.